Cited by 6Neurofibromatosis and Schwannoma CasesNeuroblastoma Research and TreatmentsProtein Tyrosine Phosphatases

Atypical hematologic and renal manifestations in Neurofibromatosis type I: Coincidence or pathophysiological link?

Van-Gils, Julien, Harambat, Jérôme, Jubert, Charlotte, Vidaud, Dominique, Llanas, Brigitte, Perel, Yves, Lacombe, Didier, Goizet, Cyril·2014·European Journal of Medical Genetics

Abstract

Neurofibromatosis type 1 (NF1) is an autosomal dominant, multi-system, neurocutaneous disorder that predisposes to the development of benign and malignant tumors with a birth incidence rate of 1 in 2500-3000. 50% of cases are sporadic. The diagnosis is exclusively based on clinical assessment with clinical diagnostic criteria such as café-au-lait spots, neurofibromas, axillary or groin freckling, Lisch nodules, optic pathway glioma, bony dysplasia and first-degree relative with NF1. We report a family with NF1 in which two members presented atypical clinical features in addition to the classical diagnostic criteria. Three relatives affected by NF1, a father and two of his three sons, are described. The clinical diagnosis was originally worn in all three cases, with the association many spots café-au -lait over the entire body and some axillary freckling as well as first-degree relative. One case presented an Acute Myeloid Leukemia (AML) type 2 at 10 years of age diagnosed before the revelation of bicytopenia associated pallor and isolated asthenia. A second case presented a nephrotic syndrome at 4 years of age due to the association of hydrops with headache and asthenia. Direct sequencing of NF1 led to identify the familial mutation, a previously unreported heterozygous missense mutation c.3443C > A, p.Ala1148Glu in exon 20 which segregated with all three affected patients. The family described in this report confirms the high clinical variability of NF1, even intrafamilial,…

Integrity signals

Registry

Crossref · 10.1016/j.ejmg.2014.09.001

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cited by

Sorted by citations

Authors
Van-Gils, J., Harambat, J., Jubert, C., Vidaud, D., Llanas, B., Perel, Y., Lacombe, D., & Goizet, C.
Affiliations
  • Centre Hospitalier Universitaire de Bordeaux (FR)
  • Hôpital Cochin (FR)
  • Université de Bordeaux (FR)
Venue
European Journal of Medical Genetics
Publisher
Elsevier BV
Published
2014-11
Volume
57
Issue
11-12
Pages
639-642
ISSN
1769-7212 (ISSN-L)
OpenAlex
W2071565916
Cited by
6
References
0
Citations by year
2024: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2018: 1 · 2017: 1
FWCI
0.22
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Medical Genetics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Neurofibromatosis and Schwannoma Cases
  • Health Sciences › Medicine › Neurology › Neuroblastoma Research and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Keywords
neurofibromatosis type 1, acute myeloid leukemia, nephrotic syndrome, atypical presentation, glomerular disease
MeSH terms
Proto-Oncogene Mas, Adolescent, Adult, Child, Humans, Male, Nephrotic Syndrome, Neurofibromatosis 1, Pedigree, Cafe-au-Lait Spots, Mutation, Missense, Neurofibromin 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review